Atlas Trials

A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia

Clinical trial NCT02688764 · TERMINATED

Trial details

NCT number
NCT02688764
Sponsor
Vifor Fresenius Medical Care Renal Pharma
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Hyperphosphatemia
Start date
2016-05-26
Primary completion
2019-02-21
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.